Zoono Group Limited (AU:ZNO) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zoono Group Limited announced the successful passage of all resolutions at its recent Annual General Meeting, with over 75% shareholder approval for the 2024 remuneration report. The company avoided a ‘second strike’ under the Corporations Act, ensuring stability in its governance structure. This biotech firm, known for its innovative antimicrobial solutions, continues to strengthen its market position with global regulatory approvals.
For further insights into AU:ZNO stock, check out TipRanks’ Stock Analysis page.